These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1592278)

  • 21. A realistic clinical perspective of tamoxifen and endometrial carcinogenesis.
    Assikis VJ; Neven P; Jordan VC; Vergote I
    Eur J Cancer; 1996 Aug; 32A(9):1464-76. PubMed ID: 8911103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dual breast cancers followed by endometrial cancer.
    Dimitrievich E; Sterzinger A
    S D J Med; 2002 Jun; 55(6):227-9. PubMed ID: 12082808
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of endometrial cancer in asymptomatic postmenopausal breast cancer patient treated with tamoxifen: a case report.
    Sinawat S; Chiyabutra T; Kleabkaew P
    J Med Assoc Thai; 2001 Jul; 84(7):1033-6. PubMed ID: 11759963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Postmenopausal hemorrhage and endometrial cancer in tamoxifen therapy].
    Krause A; Gerber B
    Zentralbl Gynakol; 1994; 116(1):44-7. PubMed ID: 8147180
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of tamoxifen on the cervix and uterus in women with breast cancer: experience with Iranian patients and a literature review.
    Karimi Zarchi M; Behtash N; Sekhavat L; Dehghan A
    Asian Pac J Cancer Prev; 2009; 10(4):595-8. PubMed ID: 19827876
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Re: Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14.
    Gal D; Weiselberg L; Runowicz CD
    J Natl Cancer Inst; 1994 Aug; 86(16):1252-3; author reply 1255. PubMed ID: 8040896
    [No Abstract]   [Full Text] [Related]  

  • 27. The tamoxifen controversy.
    Crabbe WW
    Oncol Nurs Forum; 1996 Jun; 23(5):761-6. PubMed ID: 8792346
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of tamoxifen in the long-term treatment and prevention of breast cancer.
    Jordan VC
    Oncology (Williston Park); 1988 Sep; 2(9):19-28. PubMed ID: 3079292
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tamoxifen therapy--long-term results and complications.
    Moore MP; Kinne DW
    Adv Surg; 1996; 29():263-9. PubMed ID: 8720007
    [No Abstract]   [Full Text] [Related]  

  • 30. A clinicopathologic study on patients with endometrial cancer after adjuvant tamoxifen treatment for breast cancer: a single center experience.
    Ravazoula P; Androutsopoulos G; Zyli P; Michail G; Kardamakis DM; Kourounis G
    Breast J; 2006; 12(6):578-84. PubMed ID: 17238994
    [No Abstract]   [Full Text] [Related]  

  • 31. Benign gynecologic conditions among participants in the Breast Cancer Prevention Trial.
    Chalas E; Costantino JP; Wickerham DL; Wolmark N; Lewis GC; Bergman C; Runowicz CD
    Am J Obstet Gynecol; 2005 Apr; 192(4):1230-7; discussion 1237-9. PubMed ID: 15846210
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overview from the International Conference on Long-Term Tamoxifen Therapy for Breast Cancer.
    Jordan VC
    J Natl Cancer Inst; 1992 Feb; 84(4):231-4. PubMed ID: 1346404
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Re: Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14.
    Carcangiu ML
    J Natl Cancer Inst; 1994 Aug; 86(16):1251-2; author reply 1253-5. PubMed ID: 8040895
    [No Abstract]   [Full Text] [Related]  

  • 34. ACOG committee opinion. Tamoxifen and endometrial cancer. Number 169, February 1996. Committee on Gynecologic Practice. American College of Obstetricians and Gynecologists.
    Int J Gynaecol Obstet; 1996 May; 53(2):197-9. PubMed ID: 8735304
    [No Abstract]   [Full Text] [Related]  

  • 35. Gynecologic tumors in tamoxifen-treated women with breast cancer.
    Seoud MA; Johnson J; Weed JC
    Obstet Gynecol; 1993 Aug; 82(2):165-9. PubMed ID: 8393156
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Population-based study of tamoxifen therapy and subsequent ovarian, endometrial, and breast cancers.
    Cook LS; Weiss NS; Schwartz SM; White E; McKnight B; Moore DE; Daling JR
    J Natl Cancer Inst; 1995 Sep; 87(18):1359-64. PubMed ID: 7658496
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Risk of endometrial hyperplasia and carcinoma in breast cancer patients receiving adjuvant tamoxifen].
    Semiglazov VF; Maksimov SIa; Bulgatova EA; Meshkova IE; Chepik OF; Berstein LM
    Vopr Onkol; 2003; 49(2):198-204. PubMed ID: 12785205
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ACOG committee opinion. No. 336: Tamoxifen and uterine cancer.
    American College of Obstetricians and Gynecologists Committee on Gynecologic Practice
    Obstet Gynecol; 2006 Jun; 107(6):1475-8. PubMed ID: 16738185
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cancer of the endometrium caused by antiestrogens].
    Le Bouëdec G; Dauplat J
    Rev Fr Gynecol Obstet; 1992 Jun; 87(6):345-8. PubMed ID: 1631476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The nature of tamoxifen action in the control of female breast cancer.
    Kodama M; Kodama T
    In Vivo; 2001; 15(4):319-25. PubMed ID: 11695224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.